ASC30 for Weight Management
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests tablets called ASC30 to evaluate their effectiveness in weight management. Researchers aim to ensure these tablets are safe, effective, and easy to tolerate. Participants will be divided into groups, with some receiving ASC30 tablets and others a placebo (a pill that resembles the real thing but contains no active ingredients). This trial may suit individuals without significant health issues who are interested in managing their weight. As a Phase 2 trial, the research focuses on measuring the treatment's effectiveness in an initial, smaller group of people.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial team or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that ASC30 tablets are generally safe for people. In earlier studies, ASC30 was well-tolerated, with most participants experiencing no major issues. Most side effects were mild to moderate and primarily affected the stomach. No serious problems were reported. This suggests that while some individuals might experience mild stomach issues, serious problems are unlikely.12345
Why are researchers excited about this trial's treatments?
Researchers are excited about ASC30 because it offers a unique approach to weight management by potentially targeting metabolic pathways that current treatments do not. Most existing treatments focus on appetite suppression or fat absorption inhibition, but ASC30 might work differently by affecting the body's energy balance at a cellular level. This novel mechanism could lead to more efficient weight loss with possibly fewer side effects, making it a promising option for those who have not responded well to other treatments.
What evidence suggests that this trial's treatments could be effective for weight management?
Research has shown that ASC30 Tablets can aid in weight management. In earlier studies, participants taking ASC30 once daily lost up to 6.5% of their body weight in just 28 days, compared to those taking a placebo (a pill with no active ingredients). This indicates that the drug helped participants lose more weight than those not taking it. The tablets were also well-tolerated, meaning they are generally safe and easy to use. These findings suggest that ASC30 could be effective for individuals struggling to lose weight. Participants in this trial will receive either ASC30 tablets, ASC30 tablets A1, or a placebo to further evaluate these effects.12467
Are You a Good Fit for This Trial?
This trial is for non-smoking adults aged 18-75 who are overweight or obese with related health issues. Participants must consent to study procedures and have no significant medical findings from exams, ECGs, or vital signs measurements.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive ASC30 tablets or placebo administered orally once daily
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ASC30 Tablets
- ASC30 Tablets A1
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ascletis Pharma (China) Co., Limited
Lead Sponsor